Announce Date | 08/06/2025 |
EPS Normalized Actual | $0.165 (Beat by $0.035) |
EPS GAAP Actual | $0.165 (Beat by $0.035) |
Revenue Actual | $0.579B |
Revenue Surprise | Beat by $579M |
Announce Date | 12/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0 |
EPS GAAP Estimate | $0 |
Revenue Estimate | $0.501076529B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 0.98806 | 13.19 | 0.96385 | 1.00468 | 1 |
Dec 2028 | 0.47899 | 27.21 | 0.47429 | 0.48238 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.0079 | -0.0079 | 0.579B | 28.37% | 95.1M |
FQ1 2025 (Mar 2025) | 0.12 | 0.12 | 0.517B | 26.64% | 106.53M |
FQ4 2024 (Dec 2024) | 0.13 | 0.08343105 | 0.500003B | 28.02% | 61.17M |
FQ3 2024 (Sep 2024) | 0.0169 | -1.52451 | 0.402853B | 11.41% | -453.92M |
FQ2 2024 (Jun 2024) | -0.0016 | -1.34419 | 0.414746B | 100% | -346.83M |
FQ1 2020 (Mar 2020) | 0.5 | 0.5 | 0.196542B | 100% | 196.54M |
FQ2 2020 (Jun 2020) | 0.5 | 0.5 | 0.196542B | 100% | 196.54M |
FQ3 2020 (Sep 2020) | 0.87 | 0.87 | 0.257467B | 100% | 257.47M |
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
0.501076529B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.18701 | -- | 0.1783 | 0.19621 | 1 |
FQ3 2027 (Sep 2027) | 0.15073 | -- | 0.14371 | 0.15815 | 1 |
FQ2 2027 (Jun 2027) | 0.19212 | -- | 0.18318 | 0.20158 | 1 |
FQ1 2027 (Mar 2027) | 0.17449 | -- | 0.16637 | 0.18308 | 1 |
FQ4 2026 (Dec 2026) | 0.19812 | -- | 0.19812 | 0.19812 | 1 |
FQ3 2026 (Sep 2026) | 0.12115 | -- | 0.12115 | 0.12115 | 1 |
FQ2 2026 (Jun 2026) | 0.18419 | 104.29 | 0.18419 | 0.18419 | 1 |
FQ1 2026 (Mar 2026) | 0.10367 | -15.75 | 0.10367 | 0.10367 | 1 |
FQ4 2025 (Dec 2025) | 0 | -INF | 0 | 0 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.69B | -- | 0.66B | 0.71B | 2 |
FQ3 2027 (Sep 2027) | 0.61B | -- | 0.58B | 0.63B | 2 |
FQ2 2027 (Jun 2027) | 0.71B | -- | 0.68B | 0.73B | 2 |
FQ1 2027 (Mar 2027) | 0.66B | -- | 0.63B | 0.68B | 2 |
FQ4 2026 (Dec 2026) | 0.65B | -- | 0.65B | 0.65B | 1 |
FQ3 2026 (Sep 2026) | 0.58B | -- | 0.58B | 0.58B | 1 |
FQ2 2026 (Jun 2026) | 0.59B | 1.41 | 0.59B | 0.59B | 1 |
FQ1 2026 (Mar 2026) | 0.54B | 4.22 | 0.54B | 0.54B | 1 |
FQ4 2025 (Dec 2025) | 0.5B | 0.21 | 0.5B | 0.5B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0 | -0.0079 | -0.0079 | 100% |
FQ1 2025 (Mar 2025) | 0 | 0.12 | 0.12 | 100% |
FQ4 2024 (Dec 2024) | 0.04656895 | 0.13 | 0.08343105 | 64.18% |
FQ3 2024 (Sep 2024) | 1.54141 | 0.0169 | -1.52451 | -9020.77% |
FQ2 2024 (Jun 2024) | 1.34259 | -0.0016 | -1.34419 | 84011.88% |
FQ1 2020 (Mar 2020) | 0.5 | 0.5 | 100% | |
FQ2 2020 (Jun 2020) | 0.5 | 0.5 | 100% | |
FQ3 2020 (Sep 2020) | 0.87 | 0.87 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0.48B | $0.58B | $95.1M | 16.42% |
FQ1 2025 (Mar 2025) | $0.41B | $0.52B | $106.53M | 20.61% |
FQ4 2024 (Dec 2024) | $0.44B | $0.5B | $61.17M | 12.23% |
FQ3 2024 (Sep 2024) | $0.86B | $0.4B | $-453.92M | -112.68% |
FQ2 2024 (Jun 2024) | $0.76B | $0.41B | $-346.83M | -83.63% |
FQ1 2020 (Mar 2020) | $0B | $0.2B | $196.54M | 100% |
FQ2 2020 (Jun 2020) | $0B | $0.2B | $196.54M | 100% |
FQ3 2020 (Sep 2020) | $0B | $0.26B | $257.47M | 100% |